Literature DB >> 7789497

Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology.

J M Valle1, D Alvarez, J Antúnez, L Valdés.   

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathological entity with well-defined diagnostic criteria, the aetiology of which is generally unknown. Among the adverse pulmonary effects of the drug amiodarone, BOOP is the least commonly reported in the literature. In this article we describe a case of amiodarone-induced BOOP.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7789497     DOI： 10.1183/09031936.95.08030470

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  [Medical therapy of heart and lung diseases. Effects on the respective other organ].

Authors:  S Möhlenkamp; G Weinreich; T Neumann; T Voshaar; H Teschler
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

Review 3.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

4.  Cryptogenic organizing pneumonia due to amiodarone: long-term follow-up after corticosteroid treatment.

Authors:  Katja Schindler; Wolfgang Schima; Josef F Kaliman
Journal:  Wien Klin Wochenschr       Date:  2010-08-02       Impact factor: 1.704

Review 5.  Hemokinins and endokinins.

Authors:  N M Page
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

6.  Amiodarone-induced Hemoptysis: A Rare Presentation of Amiodarone-induced Pulmonary Toxicity Occurs at a Low Dose.

Authors:  Clayton D Busch; Caleb J Heiberger; Tej I Mehta; Douglas Yim
Journal:  Cureus       Date:  2019-07-31

7.  A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity.

Authors:  Wang Chun Kwok; Ting Fung Ma; Johnny Wai Man Chan; Herbert H Pang; James Chung Man Ho
Journal:  BMC Pulm Med       Date:  2022-04-05       Impact factor: 3.317
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.